Associate Director


Confirmed live in the last 24 hours

Voyager Therapeutics

Voyager Therapeutics

51-200 employees

Develops gene therapies for neurological diseases



Lexington, MA, USA

  • A PhD degree with 10+ years or MS with 16+ years or BS with 17+ years’ experience in the field of Neuroscience, Neurodegeneration, Pharmacology or related discipline is required.
  • Strong preference for a candidate with experience in Huntington’s Disease and/or AAV gene therapy.
  • Prior related experience, ideally with a biotechnology or other life sciences company, is preferred but not required.
  • Previous management experience required.
  • Strong background in iPS cell and primary neuronal cultures, and in vivo experimental methods including pharmacology and efficacy readouts to support candidate nomination and characterization.
  • Outstanding problem-solving skills.
  • Ability to read and interpret the literature to support advancement of programs and/or platform discovery research.
  • Ability to be highly productive in a fluid and fast-paced work environment.
  • Good communication skills and ability to multi-task.
  • Developments of pre-clinical program plans in research, communication of status and progress, and sharing of expertise with others.
  • Strong commitment to accountability for completion of projects in accordance with team and company goals.
  • Excellent organizational skill and attention to detail.
  • Thrives in a team-oriented, fast-paced, and cross-disciplinary start-up biotech environment.
  • Design, execute experiments, analyze data, and report readouts (both written and verbal) for AAV platform discovery research.
  • Support the Research team in completion of in vitro and in vivo screens to support target validation through lead characterization.
  • Strong working experience in analyzing DNA, mRNA and protein assays from both tissue and cell culture studies.
  • Collaborate with the research team to analyze data and independently deliver effective presentations summarizing data and key decisions to all stakeholders (Internal and External Research teams and Senior Leaders)
  • Ensures maintenance of industry-quality records to provide documentation.

Voyager Therapeutics, Inc. excels in the field of gene therapy, specializing in innovative solutions for central nervous system diseases. Their TRACER™ AAV capsid discovery platform stands out for improving drug delivery across the blood-brain barrier, a crucial factor in treating disorders like Alzheimer’s, ALS, and Parkinson’s. The culture of collaboration, evidenced by partnerships with major pharmaceutical companies, and a strong focus on neurology research positions this company as a leading environment for professionals passionate about breakthroughs in medical science.

Company Stage


Total Funding



Cambridge, Massachusetts



Growth & Insights

6 month growth


1 year growth


2 year growth